Encoding mu-opioid receptor biased agonism with interaction fingerprints
- 29 October 2021
- journal article
- research article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 35 (11) , 1081-1093
Abstract
Opioids are potent painkillers, however, their therapeutic use requires close medical monitoring to diminish the risk of severe adverse effects. The G-protein biased agonists of the μ-opioid receptor (MOR) have shown safer therapeutic profiles than non-biased ligands. In this work, we performed extensive all-atom molecular dynamics simulations of two markedly biased ligands and a balanced reference molecule. From those simulations, we identified a protein–ligand interaction fingerprint that characterizes biased ligands. Then, we built and virtually screened a database containing 68,740 ligands with proven or potential GPCR agonistic activity. Exemplary molecules that fulfill the interacting pattern for biased agonism are showcased, illustrating the usefulness of this work for the search of biased MOR ligands and how this contributes to the understanding of MOR biased signaling.Keywords
Funding Information
- DGAPA, UNAM (PASPA)
- National Institute on Drug Abuse (R33DA044425)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
This publication has 69 references indexed in Scilit:
- The Role of Water and Sodium Ions in the Activation of the μ‐Opioid ReceptorAngewandte Chemie International Edition, 2013
- A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with MorphineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Principal component and clustering analysis on molecular dynamics data of the ribosomal L11·23S subdomainJournal of Molecular Modeling, 2012
- Structure of the δ-opioid receptor bound to naltrindoleNature, 2012
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized BornJournal of Chemical Theory and Computation, 2012
- Crystal structure of the µ-opioid receptor bound to a morphinan antagonistNature, 2012
- 2-Methoxymethyl-Salvinorin B Is a Potent κ Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin AThe Journal of Pharmacology and Experimental Therapeutics, 2008
- The Many Roles of Computation in Drug DiscoveryScience, 2004
- The [35S]GTPγS binding assay: approaches and applications in pharmacologyLife Sciences, 2003
- Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the μ opioid receptorFEBS Letters, 1999